Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands
Source
European journal of cancer - ISSN 1879-0852-205 (2024) p. 1-7
De benadering van menopauzale klachten bij patiënten met borstcarcinoom
Source
Gunaïkeia: Nederlandse uitgave - ISSN 1373-6647-29:3 (2024) p. 6-16
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)
Source
International journal of gynecological cancer - ISSN 1048-891X- (2024) p.
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer-treated with neoadjuvant systemic therapy
Source
Cancer research communications - ISSN 2767-9764-4:1 (2024) p. 186-199
Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy : a focus on patient's safety and radiation protection
Source
Radiotherapy and oncology - ISSN 0167-8140-196 (2024) p. 1-8